Is hypofractionation acceptable for prostate bed radiotherapy?

Approximately 30% of patients who undergo radical prostatectomy for prostate cancer develop disease progression. The only potentially curative treatment in these patients is postoperative radiotherapy with or without hormonotherapy. One of the standards of care in nonsurgical patients is hypofractio...

Full description

Saved in:
Bibliographic Details
Published in:Urologic oncology 2021-06, Vol.39 (6), p.346-350
Main Authors: López Campos, Fernando, Sancho Pardo, Gemma, Maldonado Pijoan, Xavier, Zilli, Thomas, Couñago Lorenzo, Felipe, Hervás Morón, Asunción
Format: Article
Language:English
Subjects:
Adjuvant and salvage radiotherapy
Hypofractionation radiotherapy
Prostate bed radiotherapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Approximately 30% of patients who undergo radical prostatectomy for prostate cancer develop disease progression. The only potentially curative treatment in these patients is postoperative radiotherapy with or without hormonotherapy. One of the standards of care in nonsurgical patients is hypofractionated radiotherapy. However, the current evidence based is insufficient to define the optimal dose and fractionation schedule for postoperative radiotherapy. In this context, the aim of this editorial is to assess the main efficacy and toxicity data for postoperative hypofractionated radiotherapy and discuss the potential to implement this fractionation in routine clinical practice.
ISSN:1078-1439
1873-2496
DOI:10.1016/j.urolonc.2021.02.002